FDA rejects Biogen's high-dose SPINRAZA application, citing manufacturing issues

{
  "signal_id": "d85299f1-f7ef-4b50-9087-903d3982c41b",
  "signal_type": "sec-10k",
  "signal_subtype": "productLaunch",
  "detected_at": "2026-02-10T07:50:47.777+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "detail": "The FDA issued a Complete Response Letter (CRL) for a higher dose of SPINRAZA, requesting updates to Chemistry, Manufacturing, and Controls (CMC) information. This regulatory setback creates an urgent need to address technical and manufacturing deficiencies, opening doors for regulatory consultants and CMC specialists to help secure approval by the new April 2026 PDUFA date.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "FDA rejects Biogen's high-dose SPINRAZA application, citing manufacturing issues",
    "excerpts": "In September 2025 the FDA issued a CRL for the supplemental NDA for a higher dose regimen of nusinersen for the treatment of SMA.",
    "relevance": 0.75,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm",
    "filing_date": "2026-02-06",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Go-to-market support",
    "signal_category": "strategic",
    "regions_mentioned": [
      "U.S."
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/d85299f1-f7ef-4b50-9087-903d3982c41b \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","limit":20}'